S E Mirski

1.5k total citations
28 papers, 1.3k citations indexed

About

S E Mirski is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, S E Mirski has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Oncology and 4 papers in Neurology. Recurrent topics in S E Mirski's work include Cancer therapeutics and mechanisms (19 papers), Lung Cancer Research Studies (12 papers) and Drug Transport and Resistance Mechanisms (4 papers). S E Mirski is often cited by papers focused on Cancer therapeutics and mechanisms (19 papers), Lung Cancer Research Studies (12 papers) and Drug Transport and Resistance Mechanisms (4 papers). S E Mirski collaborates with scholars based in Canada, United States and Australia. S E Mirski's co-authors include Susan P.C. Cole, James H. Gerlach, Qiang Yu, H. Downes, Peter A. Greer, Ralph Zirngibl, Pamela W. Feldhoff, Daniel M. Sullivan, A. Dean Befus and Mark R. McDermott and has published in prestigious journals such as Nucleic Acids Research, Biochemistry and Biochemical Journal.

In The Last Decade

S E Mirski

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S E Mirski Canada 21 934 762 127 99 98 28 1.3k
D. Parker Suttle United States 18 1.4k 1.5× 645 0.8× 52 0.4× 137 1.4× 110 1.1× 34 1.6k
N Rosen United States 11 637 0.7× 457 0.6× 66 0.5× 53 0.5× 53 0.5× 20 978
Jaulang Hwang Taiwan 17 594 0.6× 388 0.5× 58 0.5× 43 0.4× 69 0.7× 34 1.0k
Elizabeth Lovelace United States 14 616 0.7× 594 0.8× 134 1.1× 127 1.3× 141 1.4× 18 1.2k
Benjamin T. Vroman United States 20 1.1k 1.1× 732 1.0× 294 2.3× 103 1.0× 207 2.1× 24 1.8k
Ming Chu United States 17 678 0.7× 259 0.3× 128 1.0× 150 1.5× 182 1.9× 49 1.2k
Uppoor G. Bhat United States 18 1000 1.1× 326 0.4× 73 0.6× 25 0.3× 65 0.7× 32 1.2k
Peter J. Welch United States 18 1.1k 1.2× 551 0.7× 43 0.3× 32 0.3× 126 1.3× 24 1.7k
Randy A. Hock United States 18 865 0.9× 246 0.3× 82 0.6× 36 0.4× 78 0.8× 20 1.3k
James R. Zucali United States 19 593 0.6× 470 0.6× 45 0.4× 83 0.8× 94 1.0× 42 1.5k

Countries citing papers authored by S E Mirski

Since Specialization
Citations

This map shows the geographic impact of S E Mirski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S E Mirski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S E Mirski more than expected).

Fields of papers citing papers by S E Mirski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S E Mirski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S E Mirski. The network helps show where S E Mirski may publish in the future.

Co-authorship network of co-authors of S E Mirski

This figure shows the co-authorship network connecting the top 25 collaborators of S E Mirski. A scholar is included among the top collaborators of S E Mirski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S E Mirski. S E Mirski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mirski, S E, Beate Friedrich, Matthias Köhler, et al.. (2006). Topoisomerase II binds importin α isoforms and exportin/CRM1 but does not shuttle between the nucleus and cytoplasm in proliferating cells. Experimental Cell Research. 313(3). 627–637. 12 indexed citations
2.
Mirski, S E, et al.. (2003). Identification of functional nuclear export sequences in human topoisomerase IIα and β. Biochemical and Biophysical Research Communications. 306(4). 905–911. 23 indexed citations
3.
4.
5.
Mirski, S E, Leah C. Young, Roger G. Deeley, et al.. (2000). Simultaneous Quantitation of Topoisomerase II α and β Isoform mRNAs in Lung Tumor Cells and Normal and Malignant Lung Tissue. Laboratory Investigation. 80(6). 787–795. 12 indexed citations
6.
Mirski, S E, et al.. (2000). A truncated cytoplasmic topoisomerase IIα in a drug-resistant lung cancer cell line is encoded by aTOP2A allele with a partial deletion of exon 34. International Journal of Cancer. 85(4). 534–539. 21 indexed citations
7.
Mirski, S E, James H. Gerlach, & Susan P.C. Cole. (1999). Sequence Determinants of Nuclear Localization in the α and β Isoforms of Human Topoisomerase II. Experimental Cell Research. 251(2). 329–339. 42 indexed citations
8.
Mirski, S E, et al.. (1998). Structural organization of the human TOP2A and TOP2B genes. Gene. 221(2). 255–266. 59 indexed citations
9.
Wessel, Irene, et al.. (1997). Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.. PubMed. 57(20). 4451–4. 60 indexed citations
10.
Mirski, S E, et al.. (1997). Bipartite Nuclear Localization Signals in the C Terminus of Human Topoisomerase IIα. Experimental Cell Research. 237(2). 452–455. 54 indexed citations
11.
Zalcberg, John, Xiu Feng Hu, Dominic Wall, et al.. (1994). Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line. International Journal of Cancer. 57(4). 522–528. 32 indexed citations
12.
Mirski, S E, Clive Evans, Kurt C. Almquist, ML Slovak, & Susan P.C. Cole. (1994). Altered topoisomerase IIα in a drug-resistant small cell lung cancer cell line selected in VP-16. Lung Cancer. 11(1-2). 143–143. 54 indexed citations
13.
Mirski, S E, et al.. (1994). Reduced levels of topoisomerase II? and II? in a multidrug-resistant lung-cancer cell line. Cancer Chemotherapy and Pharmacology. 34(3). 242–248. 23 indexed citations
14.
Feldhoff, Pamela W., S E Mirski, Susan P.C. Cole, & Daniel M. Sullivan. (1994). Altered subcellular distribution of topoisomerase IIα in a drug-resistant human small cell lung cancer cell line. Lung Cancer. 11(3-4). 341–341. 62 indexed citations
15.
16.
Cole, Susan P.C., et al.. (1990). Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.. Molecular Pharmacology. 37(2). 192–197. 78 indexed citations
17.
Mirski, S E & Susan P.C. Cole. (1990). Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line. Lung Cancer. 6(3-4). 124–124. 19 indexed citations
18.
Mirski, S E, James H. Gerlach, & Susan P.C. Cole. (1987). Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.. PubMed. 47(10). 2594–8. 299 indexed citations
19.
Cole, Susan P.C., S E Mirski, R.C. McGarry, et al.. (1986). Differential expression of the Leu-7 antigen on human lung tumor cells. Lung Cancer. 2(4). 252–252. 29 indexed citations
20.
Mirski, S E, Mark R. McDermott, A. Dean Befus, & John Bienenstock. (1981). Selective localization of mesenteric lymphoblasts in mucosal tissues: effects of altering the number of donor lymphoblasts.. PubMed. 43(4). 669–75. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Parker Suttle Breakdown of academic impact, for papers by N Rosen Breakdown of academic impact, for papers by Jaulang Hwang Breakdown of academic impact, for papers by Elizabeth Lovelace Breakdown of academic impact, for papers by Benjamin T. Vroman Breakdown of academic impact, for papers by Ming Chu Breakdown of academic impact, for papers by Uppoor G. Bhat Breakdown of academic impact, for papers by Peter J. Welch Breakdown of academic impact, for papers by Randy A. Hock Breakdown of academic impact, for papers by James R. Zucali
Rankless by CCL
2026